2.21
price up icon0.45%   0.010
after-market After Hours: 2.20 -0.010 -0.45%
loading

Intensity Therapeutics Inc Stock (INTS) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-30
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
41.47%
4.743
3.3527 2.4905 1.2217 1.2541
Interest Income/Expense
100.00%
-
-0.000161 - 0.2218 0.0834
Operating Income/Loss
41.47%
-4.743
-3.3527 -2.4905 -1.2217 -1.2541
Income/Loss From Continuing Operations Before Tax
45.15%
-4.603
-3.1712 -2.3297 -3.7005 -1.3365
Income/Loss From Continuing Operations After Tax
45.15%
-4.603
-3.1712 -2.3297 -3.7005 -1.3365
Net Income/Loss
45.15%
-4.603
-3.1712 -2.3297 -3.7005 -1.3365
Preferred Stock Dividends And Other Adjustments
100.00%
-
-1.3235 - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
698.76%
13.71
1.7163 13.66 3.5166 -0.0529
Diluted Average Shares
698.76%
13.71
1.7163 13.66 3.5166 -0.0529
Basic Earnings Per Share
183.33%
-0.34
-0.12 -0.17 -1.05 -0.40
Diluted Earnings Per Share
183.33%
-0.34
-0.12 -0.17 -1.05 -0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
100.00%
-
-1.3235 - - -
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Cap:     |  Volume (24h):